New York Regional Center for Diabetes Translation Research

Information

  • Research Project
  • 10290457
  • ApplicationId
    10290457
  • Core Project Number
    P30DK111022
  • Full Project Number
    2P30DK111022-07
  • Serial Number
    111022
  • FOA Number
    RFA-DK-20-002
  • Sub Project Id
    8133
  • Project Start Date
    9/20/2016 - 7 years ago
  • Project End Date
    7/31/2026 - 2 years from now
  • Program Officer Name
  • Budget Start Date
    8/1/2021 - 2 years ago
  • Budget End Date
    7/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    07
  • Suffix
  • Award Notice Date
    9/3/2021 - 2 years ago

New York Regional Center for Diabetes Translation Research

Pilot & Feasibility Program The Pilot and Feasibility Study (P&F) Program of the New York Regional Center for Diabetes Translation Research (NY-CDTR) is designed to support primarily early stage investigators (ESIs), but also established investigators in other fields to conduct research in diabetes, obesity and related cardiometabolic disorders. Proposals that investigate health disparities related to diabetes and obesity, and these areas as they relate to COVID-19, are encouraged. During our initial grant award cycle, we exceeded the mandated average of two funded proposals per year for a P&F program, having a total of 13 P&F funded grants. For this renewal application, we introduce a coordinated initiative to address racial disparities in obtaining NIH funded R01 grants. We solicit P&F proposals through our website and by email reaching out to our members and relevant departments at our member institutions to solicit P&F proposals as well as through our Enrichment Program and Cores. Overall, the goals of the P&F Program are to foster innovative areas of inquiry in diabetes or obesity both by supporting and mentoring individual P&F recipients and to encourage collaboration among NY- CDTR members. Our Specific Aims are: 1) To conduct annual P&F grant competitions. We have increased our institutional collaboration and refined our procedures for our annual competition to increase the number of responsive applications to a minimum of ten per year. We will expand the circulation of our annual solicitation for P&F proposals through new collaborations with other NIH-supported Centers..2) To increase P&F awardee and early stage investigator use of CDTR resources (Core services and Enrichment programming). We are collaborating with the Core and Enrichment leaders to increase awareness and use of NY-CDTR Core services and Program resources and to facilitate networking, which P&F awardees identified as a priority on the Spring 2020 Membership Survey. 3) To objectively evaluate P&F awardee progress. We are formalizing our evaluation metrics for all P&F projects to include a quarterly checklist-type status update that reports on milestones achieved. 4) To increase P&F applications from URiM investigators and evaluate relevant funding metrics. The P&F program will collaborate with the Enrichment Program and the Administrative Core to engage the membership network, pipeline programs, and Diversity Supplement grant recipients to solicit P&F proposals. We will assess barriers and facilitators for URiM early stage investigators in obtaining R01 funding.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    P30
  • Administering IC
    DK
  • Application Type
    2
  • Direct Cost Amount
    107287
  • Indirect Cost Amount
    72955
  • Total Cost
  • Sub Project Total Cost
    180242
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIDDK:180242\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZDK1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ALBERT EINSTEIN COLLEGE OF MEDICINE
  • Organization Department
  • Organization DUNS
    081266487
  • Organization City
    BRONX
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    104611900
  • Organization District
    UNITED STATES